SCHEMBL20737689

SCHEMBL20737689

c1ccc2c(c1)-c1ccccc1C21c2cc3cc(-c4ccc(-c5cn6cccnc6n5)cc4)ccc3cc2-c2c1c1ccccc1c1ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 17/20 0.45
▸ KDM4E B2RXH2 16/20 0.45
▸ HPGD P15428 9/20 0.45
▸ GLA P06280 7/20 0.45
▸ HSD17B10 Q99714 4/20 0.45
▸ RAB9A P51151 12/20 0.43
▸ GAA P10253 10/20 0.43
▸ NPC1 O15118 9/20 0.43
▸ SMN1; SMN2 Q16637 7/20 0.43
▸ POLB P06746 3/20 0.43
▸ MAPT P10636 7/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ TP53 P04637 2/20 0.43
▸ GFER P55789 2/20 0.41
▸ CDC7 O00311 1/20 0.40
▸ DAPK3 O43293 1/20 0.40
▸ DYRK3 O43781 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ PRKD3 O94806 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20736933 0.88 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL20737260 0.88 RAB9A (0.45) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL20737142 0.88 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL17862603 0.87 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL20737164 0.87 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL20737684 0.86 RAB9A (0.42) ALDH1A1KDM4EHPGDHSD17B10RAB9A
SCHEMBL20736488 0.85 RAB9A (0.46) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL20736227 0.84 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL20735957 0.84 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL20735804 0.84 PDK2 (0.41) ALDH1A1KDM4EHPGDHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 — — US disclosed
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 — — US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 — — US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 ALDH1A1 125/4885KDM4E 2169/4885HPGD 4003/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 ALDH1A1 125/4885KDM4E 2169/4885HPGD 4003/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 ALDH1A1 125/4885KDM4E 2169/4885HPGD 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback